| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 88,324 | 86,206 | 77,937 | 230,715 | | Cost of Revenue | 88,645 | 91,437 | 93,413 | 235,457 | | | Gross Profit | (321) | (5,231) | (15,476) | (4,742) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,886 | 11,433 | 11,843 | 16,179 | | Non Recurring |
-
|
-
|
-
| 66,317 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (10,207) | (16,664) | (27,319) | (87,238) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (55,104) | 34 | 55 | (305) | | Earnings Before Interest And Taxes | (65,311) | (16,630) | (27,264) | (87,543) | | Interest Expense | 1,148 | 1,306 | 1,005 | 1,308 | | Income Before Tax | (66,459) | (17,936) | (28,269) | (88,851) | | Income Tax Expense | (55) | (1) | 15 | 23,055 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (66,707) | (17,935) | (28,284) | (111,906) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (66,404) | (17,935) | (28,284) | (111,906) | | Preferred Stock And Other Adjustments | (1,096) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($67,500) | ($17,935) | ($28,284) | ($111,906) |
|
0.31% Nasdaq 
0.05%
Income Statement
